Cognex Corporation (CGNX)

Cognex Corporation is a common stock listing on NASDAQ for Cognex Corporation, a technology company focused on machine vision products used to capture and analyze visual information for automation in manufacturing and distribution. Its systems help customers locate, identify, inspect, and measure discrete items across applications such as mobile phones, automotive components, and e-commerce packages. The company’s product lineup includes VisionPro software, Vision systems, OneVision, the In-Sight family, QuickBuild, DataMan barcode readers and verifiers, and related vision accessories such as cameras, lenses, lighting, controllers, frame grabbers, and I/O cards. Cognex serves industries including automotive, logistics, packaging, consumer electronics, medical-related, semiconductor, and consumer products. Incorporated in 1981 and headquartered in Natick, Massachusetts, the company operates in the United States, Europe, Greater China, and other international markets.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-CGNX
$60.21
-4.6% Downside
Fair
$77.60
23.0% Upside
Undervalued
Fair
0.34
0.5%
August 5, 2026
73.9x
7.1x
10.1x
10.498 B
9.98 B
0.7%
95.4%
13.7
38.8%
169.1%
Valuation • Fair Value

Cognex Corporation (NASDAQ-CGNX) Fair Value by Valuation Model

Compare the primary fair value estimate for Cognex Corporation (NASDAQ-CGNX) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$60.21

Estimated downside of 4.6% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$69.55

Discounted cash flow valuation reference.

Ben Graham Formula Value

$9.50

Classic Ben Graham valuation formula reference.

DDM Fair Value

$54.20

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$53.43

Comparable-company valuation reference.

Analyst Price Target

$77.60

Analysts imply upside of 23.0%.

How to read these valuation models

Use this section to compare the primary fair value estimate for Cognex Corporation (NASDAQ-CGNX) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Cognex Corporation (NASDAQ-CGNX)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.047 B

Current operating scale indicator.

Revenue Forecast

1.104 B

Forward revenue estimate.

EBITDA

226.4 M

Current operating profitability reference.

EBITDA Forecast

304 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Cognex Corporation (NASDAQ-CGNX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Cognex Corporation (NASDAQ-CGNX)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

8

Relatively strong quality score.

Beneish M-Score

-2.61

No elevated caution signal from this screen.

Altman Z-Score

13.7

Relatively strong balance-sheet zone.

FCF / Net Income

169.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Cognex Corporation (NASDAQ-CGNX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Cognex Corporation (NASDAQ-CGNX)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.5%

Income yield reference.

Upcoming Dividend

0.34

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

38.8%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Cognex Corporation (NASDAQ-CGNX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Cognex Corporation (NASDAQ-CGNX) Stock Forecast & Technical Outlook

Review Cognex Corporation (NASDAQ-CGNX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Cognex Corporation (NASDAQ-CGNX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Cognex Corporation (NASDAQ-CGNX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Cognex Corporation (NASDAQ-CGNX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for Cognex Corporation (NASDAQ-CGNX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for Cognex Corporation (NASDAQ-CGNX) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Cognex Corporation (NASDAQ-CGNX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Buy

Based on the available recommendation mix, Cognex Corporation (NASDAQ-CGNX) has a Buy consensus, with 11 buy, 5 hold and 0 sell recommendations in the current data set.

Buy 11
Hold 5
Sell 0
FAQ Fast Investor Answers

Cognex Corporation (NASDAQ-CGNX) Stock FAQ

Quick answers about Cognex Corporation (NASDAQ-CGNX) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$60.21
Estimated downside 4.6%
Valuation Rating
Overvalued
Estimated downside of 4.6%
Analyst Target
$77.60
Implied upside 23.0%
Financial Health
Fair
Current financial-health read

The current fair value estimate for Cognex Corporation (NASDAQ-CGNX) is $60.21. This implies an estimated downside of 4.6% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 4.6% versus the current market price.

The available analyst price target for Cognex Corporation (NASDAQ-CGNX) is $77.60. The analyst target implies estimated upside of 23.0%.

The current financial health read for Cognex Corporation (NASDAQ-CGNX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Cognex Corporation (NASDAQ-CGNX) is August 5, 2026.

Based on the current data, dividend yield is 0.5%, upcoming dividend amount is 0.34.

The current P/E ratio listed for Cognex Corporation (NASDAQ-CGNX) is 73.9x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Cognex Corporation is 10.498 B.

The current enterprise value listed for Cognex Corporation is 9.98 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Cognex Corporation is NASDAQ-CGNX, and the stock is listed on NASDAQ.

Cognex Corporation (NASDAQ-CGNX) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Cognex Corporation is 0.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Cognex Corporation is 95.4%. Free float helps investors understand how much of the share base is available for public trading.